Notice of Results

RNS Number : 4241B

Tissue Regenix Group PLC

16 April 2012

 



Tissue Regenix

Notification of Results

YORK, 16 April 2012 - Tissue Regenix will be announcing its preliminary results for the year ended 31 January 2012, on Thursday 10 May 2012.

A meeting for analysts will be held at the offices of FTI Consulting, 26 Southampton Buildings, London WC2A 1PB at 9:15am, with registration and coffee from 9:00am.

Enquiries:

FTI Consulting	020 7831 3113
Ben Atwell / John Dineen

Notes to Editors

About Tissue Regenix

Tissue Regenix, the RegenMed Company, was incorporated in May 2006 to commercialise the academic research of Professor Eileen Ingham and Professor John Fisher from the University of Leeds in the field of tissue decellularisation. Its dCELL® Technology comprises a patented process which removes cells and other components from human and animal tissue allowing it to be used without anti-rejection drugs to replace worn out or diseased body parts.

 

END

 

 

NORMMGMDDVDGZZM